医药导报2025，Vol.44Issue(10)：1572-1575,4.DOI:10.3870/j.issn.1004-0781.2025.10.008
伏立康唑联合环孢素致再生障碍性贫血患儿急性肾损伤的治疗分析
Treatment Analysis of Voriconazole Combined with Cyclosporine Induced Aplastic Anemia in Children with Acute Kidney Injury
摘要
Abstract
Objective To investigate the pharmaceutical monitoring for children with acute kidney injury caused by voriconazole combined with cyclosporine,in order to provide methods and ideas for clinical pharmacists to conduct pharmaceutical services.Methods The clinical pharmacist assisted physicians to analyze the causes of two episodes of abnormal renal function in the children,and used the therapeutic drug monitoring to monitor the whole process of medication.Results The child's acute kidney injury was likely to be related to medication,and physicians adopted the pharmacist's recommendation for therapeutic drug monitoring and drug adjustment,and the child didn't have any renal function abnormalities again.Conclusion Clinical pharma-cists can use pharmacokinetic knowledge and therapeutic drug monitoring methods to assist physicians in formulating and optimi-zing treatment plans,and monitor the whole process of medication for special children to ensure safety medication.关键词
伏立康唑/环孢素/再生障碍性贫血/急性肾损伤/治疗药物监测/药品不良反应Key words
Voriconazole/Cyclosporine/Aplastic anemia/Acute kidney injury/Therapeutic drug monitoring/Adverse drug reactions分类
医药卫生引用本文复制引用
岳园园,周丹丽,陈艳华,王燕..伏立康唑联合环孢素致再生障碍性贫血患儿急性肾损伤的治疗分析[J].医药导报,2025,44(10):1572-1575,4.基金项目
无锡市药品安全检验检测中心伏立康唑片药品不良反应主动监测项目. （）
